Preoperative Brimonidine on IOP of Patients Undergoing RALP
NCT02818816
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
brimonidine tartrate 0.2%
OTHER:
Carboxymethylcellulose Eye Drops
Sponsor
University Health Network, Toronto